Retinol, retinal, tretinoin — the vitamin-A family is the closest thing skincare has to a sure thing. Here's the trial that started it.
If there's one anti-aging ingredient with decades of clinical backing, it's the retinoid family — vitamin-A derivatives that nudge skin cells to behave younger.
The landmark study is from 1988. In a 16-week double-blind, vehicle-controlled trial, 30 people applied prescription tretinoin (retinoic acid) to one forearm and a plain "vehicle" cream to the other; half also treated the face. Every participant who finished showed a statistically significant improvement in photoaging on the tretinoin side — and no improvement on the vehicle side. [1] Later work using biopsies showed tretinoin actually rebuilds collagen in sun-damaged skin, not just smooths it cosmetically.
Tretinoin vs. retinol vs. retinal — the part people miss. The 1988 trial used tretinoin, a prescription drug in the US. The retinoids you buy over the counter — retinol, retinaldehyde (retinal), retinyl esters — are cosmetic ingredients your skin converts toward retinoic acid in one or more steps. Fewer steps generally means more potency and more potential irritation: retinal is one conversion away, retinol is two, retinyl palmitate is the gentlest and weakest. None are the prescription drug, and the over-the-counter versions have less direct trial evidence than tretinoin — but they work along the same pathway.
What this means in practice. Start low and infrequent (a couple of nights a week), expect weeks-to-months not days, and pair with sunscreen — retinoids and unprotected sun work against each other. The flaking and redness of the first few weeks are common and usually settle. If your skin can't tolerate it, that's exactly the gap a gentler alternative like bakuchiol tries to fill.
A 16-week trial in 30 people is a strong signal for tretinoin specifically; your mileage with an over-the-counter retinol depends on the formula, the concentration, and how consistently you use it.